Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

NINDS Advisory Council Agenda - February 16-17, 2012


Department of Health and Human Services
National Institutes of Health
National Institute of Neurological Disorders and Stroke

National Advisory Neurological Disorders and Stroke Council
183rd Meeting
February 16-17, 2012
Building 31, C Wing, 6th Floor, Conference Room 10
31 Center Drive
Bethesda, Maryland 20892
Closed Circuit Viewing Overflow (Conference Rooms 7 and 9)
Contact Number at Meeting (301) 402-8710

February 16, 2012

OPEN SESSION

8:00 a.m.
I.           Call to Order and Opening Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . .Dr. Story Landis
                                                                                                                                                    Chairperson

8:05 a.m.
II.           Report of the Associate Director for Extramural Research, NINDS . . . . . . . . . . . . .Dr. Robert Finkelstein
                                                                                                                                             

           A.        Consideration of Minutes of September 15-16, 2011, Meeting
           B.        Confirmation of Dates for Future Council Meetings
                                     May 24-25, 2012                     (Thursday and Friday)
                                     September 20-21, 2012           (Thursday and Friday)
                                     January 31-February 1, 2013    (Thursday and Friday)
                                     May 23-24, 2013                     (Thursday and Friday)
                                     September 12-13, 2013           (Thursday and Friday)

           C.        Other Items
                           Expedited Review Process
                           Council Operating Procedures
                           DER Announcements

8:15 a.m.
III.           Report of the Director, NINDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dr. Story Landis

9:00 a.m. 
IV.           Bridge Award Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dr. Alan Willard
                                                                                                Deputy Director, Division of Extramural Research
                                                                                                                                                Dr. Anna Taylor
                                                                                 Health Program Specialist, Division of Extramural Research

9:30 a.m. BREAK

9:45 a.m.
V.           Discussion of NINDS Budget Strategy 
              A.        Analysis of Past NINDS Expenditures  . . . . . . . . . . . . . . . . . . . . . . . . . . .  Dr. Robert Finkelstein
                                                                                                                                                   Dr. Paul Scott
                                                                                                    Director, Office of Science Policy and Planning
                                                                                                                                          Dr. Christine Torborg
                                                                Health Science Policy Specialist, Office of Science Policy and Planning
                                                                                                                                                  Dr. Anna Taylor
              B.        Identification of NINDS Core Principles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Amelie Gubitz
                                                                                                        Program Director, Neurodegeneration Cluster
              C.        Council Discussion

12:00 p.m.  LUNCH

1:30 p.m.
VI.           Working Group Report on the Anticonvulsant Screening Program . . . . . . . . . . . . . . . . . Dr. Robert Pacifici
                                                                                                                                      NANDS Council Member

2:00 p.m. 

CLOSED SESSION—Clinical Trial Applications

This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

VII.           Review of Conflict of Interest, Confidentiality, and Council Procedures
                 Council Consideration of Pending Applications . . . . . . . . . . . . . . .  . . . . . . .. Dr. Robert Finkelstein           
                                                                                                                          Council Executive Secretary

 

5:00 p.m.
ADJOURNMENT

February 17, 2012

CLOSED SESSION – General

8:00 a.m.
VIII.           Consideration of Pending Applications (Continued) . . . . . . . . . . . . . . . . . . . Dr. Robert Finkelstein           

11:00 a.m. **
ADJOURNMENT
**This time is tentative

Last updated January 24, 2012